105 related articles for article (PubMed ID: 20074285)
1. Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases.
Soilu-Hänninen M; Broberg E; Röyttä M; Mattila P; Rinne J; Hukkanen V
Acta Neurol Scand; 2010 Jan; 121(1):44-50. PubMed ID: 20074285
[TBL] [Abstract][Full Text] [Related]
2. Expression of leukemia inhibitory factor and leukemia inhibitory factor receptor in the canine pituitary gland and corticotrope adenomas.
Hanson JM; Mol JA; Meij BP
Domest Anim Endocrinol; 2010 May; 38(4):260-71. PubMed ID: 20036483
[TBL] [Abstract][Full Text] [Related]
3. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.
Ogawa K; Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Fujino Y; Nakajima M; Yamamoto T; Akatsu H; Mitsui S; Yamaguchi N
Psychiatry Clin Neurosci; 2000 Aug; 54(4):419-26. PubMed ID: 10997858
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor protein and receptors are expressed in the bovine adrenal cortex and increase cortisol and decrease adrenal androgen release.
Woods AM; McIlmoil CJ; Rankin EN; Packer AA; Stevens JC; Macievic JA; Brown AB; Porter JP; Judd AM
Domest Anim Endocrinol; 2008 Aug; 35(2):217-30. PubMed ID: 18638665
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
6. Expression of leukemia inhibitory factor and its receptor is not altered in the decidua and chorionic villi of human anembryonic pregnancy.
Chen HF; Chao KH; Shew JY; Yang YS; Ho HN
Hum Reprod; 2004 Jul; 19(7):1647-54. PubMed ID: 15180980
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients.
Petrozzi L; Lucetti C; Scarpato R; Gambaccini G; Trippi F; Bernardini S; Del Dotto P; Migliore L; Bonuccelli U
Neurol Sci; 2002 Sep; 23 Suppl 2():S97-8. PubMed ID: 12548361
[TBL] [Abstract][Full Text] [Related]
8. Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
Culpan D; Cornish A; Love S; Kehoe PG; Wilcock GK
Exp Gerontol; 2007 Jun; 42(6):538-44. PubMed ID: 17267158
[TBL] [Abstract][Full Text] [Related]
9. Herpesviruses in brains in Alzheimer's and Parkinson's diseases.
Hemling N; Röyttä M; Rinne J; Pöllänen P; Broberg E; Tapio V; Vahlberg T; Hukkanen V
Ann Neurol; 2003 Aug; 54(2):267-71. PubMed ID: 12891684
[TBL] [Abstract][Full Text] [Related]
10. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
11. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
Song H; Lim H
Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
[TBL] [Abstract][Full Text] [Related]
12. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
Jellinger K
J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
[TBL] [Abstract][Full Text] [Related]
14. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
Harris CD; Ermak G; Davies KJ
FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
[TBL] [Abstract][Full Text] [Related]
15. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment.
Zhou Y; Dougherty JH; Hubner KF; Bai B; Cannon RL; Hutson RK
Alzheimers Dement; 2008 Jul; 4(4):265-70. PubMed ID: 18631977
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease is associated with hippocampal atrophy.
Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
[TBL] [Abstract][Full Text] [Related]
17. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
18. Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
Kamohara H; Ogawa M; Ishiko T; Sakamoto K; Baba H
Int J Oncol; 2007 Apr; 30(4):977-83. PubMed ID: 17332938
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta-peptide and the dementia of Parkinson's disease.
Jendroska K; Lees AJ; Poewe W; Daniel SE
Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
[TBL] [Abstract][Full Text] [Related]
20. Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease.
Rensink AA; Gellekink H; Otte-Höller I; ten Donkelaar HJ; de Waal RM; Verbeek MM; Kremer B
Acta Neuropathol; 2002 Nov; 104(5):525-33. PubMed ID: 12410400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
